Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
University of Nebraska
M.D. Anderson Cancer Center
Brown University
Baylor College of Medicine
Scripps Health
Dana-Farber Cancer Institute
Wake Forest University Health Sciences
Case Comprehensive Cancer Center
University of Washington
NYU Langone Health
Southwestern Regional Medical Center
University of Michigan Rogel Cancer Center